{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T20:36:43Z","timestamp":1792442203041,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,4,23]],"date-time":"2019-04-23T00:00:00Z","timestamp":1555977600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81660106"],"award-info":[{"award-number":["81660106"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.biopha.2019.108901","type":"journal-article","created":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T08:06:50Z","timestamp":1557389210000},"page":"108901","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["HBOA ameliorates CCl4-incuded liver fibrosis through inhibiting TGF-\u03b21\/Smads, NF-\u03baB and ERK signaling pathways"],"prefix":"10.1016","volume":"115","author":[{"given":"Xuemei","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiukun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xunshuai","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyan","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiugui","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunyu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Facheng","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"e89878","key":"10.1016\/j.biopha.2019.108901_bib0005","article-title":"Pharmacological intervention in hepatic stellate cell activation and hepatic fibrosis","volume":"7","author":"Schon","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2019.108901_bib0010","series-title":"Mechanisms of Hepatic Fibrogenesis","author":"Friedman","year":"2004"},{"key":"10.1016\/j.biopha.2019.108901_bib0015","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.intimp.2017.10.028","article-title":"Gypsophila elegans isoorientin-2\u2033-O-\u03b1-l-arabinopyranosyl ameliorates porcine serum-induced immune liver fibrosis by inhibiting NF-\u03baB signaling pathway and suppressing HSC activation","author":"Bai","year":"2018","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2019.108901_bib0020","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3181\/0707-MR-190","article-title":"Mechanisms of fibrogenesis","volume":"233","author":"Kisseleva","year":"2008","journal-title":"Exp. Biol. Med."},{"issue":"2","key":"10.1016\/j.biopha.2019.108901_bib0025","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1136\/gut.2005.088690","article-title":"Emerging insights into transforming growth factor beta Smad signal in hepatic fibrogenesis","volume":"56","author":"Inagaki","year":"2007","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.biopha.2019.108901_bib0030","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1002\/hep.20194","article-title":"Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis","volume":"39","author":"Liu","year":"2004","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.biopha.2019.108901_bib0035","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/hep.21802","article-title":"Nuclear factor-kappaB and the hepatic inflammation-fibrosis-cancer axis","volume":"46","author":"Elsharkawy","year":"2007","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.biopha.2019.108901_bib0040","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0168-8278(00)80159-2","article-title":"Nuclear factor kappaB in proliferation, activation, and apoptosis in rat hepatic stellate cells","volume":"33","author":"Lang","year":"2000","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.biopha.2019.108901_bib0045","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/hep.24011","article-title":"C-reactive protein impairs hepatic insulin sensitivity and insulin signaling in rats: role of mitogen-activated protein kinases","volume":"53","author":"Xi","year":"2011","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.biopha.2019.108901_bib0050","doi-asserted-by":"crossref","first-page":"796","DOI":"10.3892\/etm.2013.1189","article-title":"Synthesis and hepatoprotective properties of Acanthus ilicifolius alkaloid A and its derivatives","volume":"6","author":"Lin","year":"2013","journal-title":"Exp. Ther. Med."},{"issue":"4","key":"10.1016\/j.biopha.2019.108901_bib0055","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/bab.1292","article-title":"The protective effects of Acanthus ilicifolius alkaloid A and its derivatives on pro- and anti-inflammatory cytokines in rats with hepatic fibrosis","volume":"62","author":"Wai","year":"2015","journal-title":"Biotechnol. Appl. Biochem."},{"issue":"4","key":"10.1016\/j.biopha.2019.108901_bib0060","doi-asserted-by":"crossref","first-page":"4895","DOI":"10.3892\/mmr.2015.4069","article-title":"Geranylgeranylacetone attenuates hepatic fibrosis by increasing the expression of heat shock protein 70","volume":"12","author":"Wei","year":"2015","journal-title":"Mol. Med. Rep."},{"issue":"6","key":"10.1016\/j.biopha.2019.108901_bib0065","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1158\/1541-7786.MCR-08-0093","article-title":"Effects of Raf kinase inhibitor protein expression on metastasis and progression of human epithelial ovarian cancer","volume":"6","author":"Li","year":"2008","journal-title":"Mol. Cancer Res."},{"issue":"6","key":"10.1016\/j.biopha.2019.108901_bib0070","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/PL00000209","article-title":"Comparative quantification of IL-1 \u03b2, IL-10, IL-10r, TNF \u03b1 and IL-7 mRNA levels in UV-irradiated human skin in vivo","volume":"49","author":"Brink","year":"2000","journal-title":"Inflamm. Res."},{"issue":"1","key":"10.1016\/j.biopha.2019.108901_bib0075","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1743-422X-8-53","article-title":"A brief review on molecular, genetic and imaging techniques for HCV fibrosis evaluation","volume":"8","author":"Ahmad","year":"2011","journal-title":"Virol. J."},{"issue":"42","key":"10.1016\/j.biopha.2019.108901_bib0080","doi-asserted-by":"crossref","first-page":"11887","DOI":"10.3748\/wjg.v21.i42.11887","article-title":"Hepatic immune tolerance induced by hepatic stellate cells","volume":"21","author":"Hsieh","year":"2015","journal-title":"World J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.biopha.2019.108901_bib0085","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1053\/j.jrn.2006.04.015","article-title":"Oxidative stress: an accomplice to uremic toxicity?","volume":"16","author":"Mircescu","year":"2006","journal-title":"J. Ren. Nutr."},{"issue":"1","key":"10.1016\/j.biopha.2019.108901_bib0090","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/hep.510290108","article-title":"Effects of Sho-saiko-to, a Japanese herbal medicine, on hepatic fibrosis in rats","volume":"29","author":"Shimizu","year":"2010","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.biopha.2019.108901_bib0095","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2174\/1568010054526359","article-title":"Nitric oxide production and signaling in inflammation","volume":"4","author":"Korhonen","year":"2005","journal-title":"Curr. Drug Targets - Inflamm. Allergy"},{"issue":"3","key":"10.1016\/j.biopha.2019.108901_bib0100","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/ptr.3539","article-title":"Effects of armepavine against hepatic fibrosis induced by thioacetamide in rats","volume":"26","author":"Weng","year":"2012","journal-title":"Phytother. Res."},{"issue":"30","key":"10.1016\/j.biopha.2019.108901_bib0105","doi-asserted-by":"crossref","first-page":"18391","DOI":"10.1074\/jbc.M115.657155","article-title":"The werner protein acts as a coactivator of nuclear factor \u03baB (NF-\u03baB) on HIV-1 and Interleukin-8 (IL-8) promoters","volume":"290","author":"Mizutani","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2019.108901_bib0110","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000452536","article-title":"The epigenetically-regulated microRNA-378a targets TGF-\u00ce\u00b22 in TGF-\u00ce\u00b21-treated hepatic stellate cells","volume":"40","author":"Yu","year":"2016","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.biopha.2019.108901_bib0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2014.09.035","article-title":"Artesunate ameliorates hepatic fibrosis induced by bovine serum albumin in rats through regulating matrix metalloproteinases","volume":"744","author":"Xu","year":"2014","journal-title":"Eur. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.biopha.2019.108901_bib0120","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1038\/labinvest.2009.77","article-title":"Therapeutic targeting of the PDGF and TGF-beta-signaling pathways in hepatic stellate cells by PTK787\/ZK22258","volume":"89","author":"Liu","year":"2009","journal-title":"Lab. Invest."},{"issue":"2","key":"10.1016\/j.biopha.2019.108901_bib0125","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3746\/pnf.2013.18.2.124","article-title":"Hepatic fibrosis inhibitory effect of peptides isolated from Navicula incerta on TGF-\u03b21 induced activation of LX-2 human hepatic stellate cells","volume":"18","author":"Kang","year":"2013","journal-title":"Prev. Nutr. Food Sci."},{"issue":"2","key":"10.1016\/j.biopha.2019.108901_bib0130","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1136\/gut.2005.088690","article-title":"Emerging insights into transforming growth factor beta Smad signal in hepatic fibrogenesis","volume":"56","author":"Inagaki","year":"2007","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.biopha.2019.108901_bib0135","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.jhep.2010.11.035","article-title":"Inhibition of PDGF, TGF-\u03b2, and Abl signaling and reduction of liver fibrosis by the small molecule Bcr-Abl tyrosine kinase antagonist Nilotinib","volume":"55","author":"Liu","year":"2011","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.biopha.2019.108901_bib0140","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1152\/ajprenal.00300.2002","article-title":"TGF- signal transduction and mesangial cell fibrogenesis","volume":"284","author":"Williamschnaper","year":"2003","journal-title":"AJP-Ren. Physiol."},{"issue":"1","key":"10.1016\/j.biopha.2019.108901_bib0145","first-page":"269","article-title":"Cytokines induce NF-\u03baB in activated but not in quiescent rat hepatic stellate cells","volume":"275","author":"Hellerbrand","year":"1998","journal-title":"Am. J. Physiol."},{"issue":"6","key":"10.1016\/j.biopha.2019.108901_bib0150","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s10620-014-3167-6","article-title":"Caspase 3 inactivation protects against hepatic cell death and ameliorates fibrogenesis in a diet-induced NASH model","volume":"59","author":"Thapaliya","year":"2014","journal-title":"Dig. Dis. Sci."},{"issue":"8","key":"10.1016\/j.biopha.2019.108901_bib0155","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1136\/gut.2005.082701","article-title":"Overexpression of Bcl-2 by activated human hepatic stellate cells: resistance to apoptosis as a mechanism of progressive hepatic fibrogenesis in humans","volume":"55","author":"Novo","year":"2006","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.biopha.2019.108901_bib0160","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/nm0511-552","article-title":"Scraping fibrosis: expressway to the core of fibrosis","volume":"17","author":"Mehal","year":"2011","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.biopha.2019.108901_bib0165","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jep.2009.03.005","article-title":"Therapeutic efficacy of Traditional Chinese Medicine 319 recipe on hepatic fibrosis induced by carbon tetrachloride in rats","volume":"124","author":"Cheung","year":"2009","journal-title":"J. Ethnopharmacol."},{"issue":"3","key":"10.1016\/j.biopha.2019.108901_bib0170","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1023\/A:1026630129025","article-title":"Plasma levels of matrix metalloproteinase-2 (MMP-2) and tissue inhibitors of metalloproteinases-1 and -2 (TIMP-1 and TIMP-2) as noninvasive markers of liver disease in chronic hepatitis C comparison using ROC analysis","volume":"44","author":"Walsh","year":"1999","journal-title":"Dig. Dis. Sci."},{"issue":"5\u20136","key":"10.1016\/j.biopha.2019.108901_bib0175","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2119\/molmed.2009.00109","article-title":"Human neutrophil elastase-mediated cleavage sites of MMP-9 and TIMP-1: implications to cystic fibrosis proteolytic dysfunction","volume":"16","author":"Jackson","year":"2010","journal-title":"Mol. Med."},{"issue":"1","key":"10.1016\/j.biopha.2019.108901_bib0180","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0168-8278(05)80181-3","article-title":"Early colchicine administration reduces hepatic fibrosis and portal hypertension in rats with bile duct ligation","volume":"19","author":"Poo","year":"1993","journal-title":"J. Hepatol."},{"issue":"68","key":"10.1016\/j.biopha.2019.108901_bib0185","first-page":"281","article-title":"Colchicine treatment of liver fibrosis","volume":"53","author":"Nikolaidis","year":"2006","journal-title":"Hepato-gastroenterology"},{"key":"10.1016\/j.biopha.2019.108901_bib0190","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jep.2017.08.029","article-title":"Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-\u03b2\/Smad and NF-\u03baB signaling pathways","volume":"210","author":"Liu","year":"2017","journal-title":"J. Ethnopharmacol."},{"issue":"5","key":"10.1016\/j.biopha.2019.108901_bib0195","doi-asserted-by":"crossref","first-page":"754","DOI":"10.3390\/molecules22050754","article-title":"Protective effects of amarogentin against carbon tetrachloride-induced liver fibrosis in mice","volume":"22","author":"Zhang","year":"2017","journal-title":"Molecules"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333221930215X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333221930215X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T11:42:02Z","timestamp":1760096522000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333221930215X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":39,"alternative-id":["S075333221930215X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2019.108901","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HBOA ameliorates CCl4-incuded liver fibrosis through inhibiting TGF-\u03b21\/Smads, NF-\u03baB and ERK signaling pathways","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2019.108901","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"108901"}}